Highlights from the October 2014 WikiLeaks Text

  • A measure that could expand online service provider surveillance of Internet users’ activity, including in the United States;
  • A rule to require the patenting of plant-related inventions, such as the genes inserted into genetically modified plants, putting farmers in developing countries at the mercy of the agriculture industry, including seed manufacturers such as Monsanto, and threatening food security in these countries more broadly;
  • Proposals for mitigating the pact’s harms to access to medicines in developing countries, none of which will suffice;
  • The elimination of proposals for patents on surgical methods;
  • A reduction in scope of other proposed monopoly protections for the pharmaceutical industry; and
  • The expected failure of a thinly veiled U.S. attack on an India-style pro-competition patent law, which facilitates access to medicines.

In the Media

WikiLeaks Publishes TPP Intellectual Property Chapter

Public Citizen Analyses of the Newly Leaked Intellectual Property Chapter

More Analyses of Plant-Related Intellectual Property

Derechos Digitales Analyses of the Newly Leaked Intellectual Property Chapter

Other Organizations' Analyses of the Newly Leaked Intellectual Property Chapter

Attack on Affordability of Cancer Treatments Revealed in New WikiLeaks Trans-Pacific Trade Pact Text

Obama Administration Budget Pledge to Cut Medicare, Medicaid Costs Would Be Undermined

October 16, 2014

WASHINGTON, D.C. – Access to affordable cancer treatments in the U.S and 11 other countries would be delayed for years if terms revealed today in the leaked draft Intellectual Property Chapter of the Trans-Pacific Partnership (TPP) were to go into effect, Public Citizen said. The text, obtained by WikiLeaks, analyzed in collaboration with Public Citizen and released today also shows worrying developments on other patent and copyright issues and explains in part why TPP talks remain deadlocked a month before President Barack Obama’s declared deadline for a deal.

“The leak shows our government demanding rules that would lead to preventable suffering and death in Pacific Rim countries, while eliminating opportunities to ease financial hardship on American families and our health programs at home,” said Peter Maybarduk, director of Public Citizen’s Global Access to Medicines Program. Public Citizen’s analysis and background information is available at http://www.citizen.org/tpp-ip-wikileaks. Continue reading...

Public Citizen Resource Page on WikiLeaks' Release of the November 2013 TPP IP Chapter

More Resources from Public Citizen's Global Access to Medicines Program on the TPP

Back to Access to Medicines Page

Copyright © 2017 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.